The U.S. Centers for Disease Control and Prevention (CDC) has asked states to make every effort to be ready to distribute a vaccine starting in November if the vaccine is effective.
With nearly 6.1 million people contaminated and 185,000 deaths, the United States is among the countries most affected by the Covid-19 health crisis. The American president Donald Trump had declared during one of his press conferences, hoping to have a vaccine for “this year”. A few days before the elections scheduled for November 3, the American Center for Disease Control and Prevention (CDC), has “urgently” asked the States by mail to ensure that the distribution centers for a possible future vaccine are “fully operational by November 1”, reports France Info.
A tactic in the run-up to the elections?
In the letter, mention would be made of the lifting of any administrative constraints (licence or permit agreement) that could delay the implementation of the project that appears to be urgent. Are they really about to release a vaccine? Or is this simply a political tactic by the President, who has been strongly criticized for his management of the epidemic and who is falling in the polls in the run-up to the elections?
A vaccine by the end of the year according to Dr. Anthony Fauci
In July 2015, Dr. Anthony Fauci, the 79-year-old world-renowned expert adviser to the White House on the coronavirus crisis who has often made a buzz for reframing Donald Trump’s statements about Covid-19 and about too rapid a deconfinement, expressed optimism about vaccine production during a video conference by predicting its availability “within a year to a year and a half”. A month and a half later, on September 2, the same adviser announced in a video on NBC news that a safe and effective vaccine would be available before the end of the year now. The relationship between the president and the expert has always been stormy, and in polls Americans say they are more confident in Dr. Anthony Fauci than their president.
In the meantime, no vaccine has yet been officially validated, except for the vaccine from Russia, which many scientists fear could be rushed through safety checks. It is currently being tested by 40,000 volunteers in phase 3. The government spokesman announced its availability in September.
In the rest of the world, research avenues continue to be explored, many are currently in the clinical phase and approaching the final trials for approval, but the dates given so far speak more of a product available for early 2021.